Table 3 Demographic and biochemical baseline characteristics of the subjects.

From: Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects

Parameter

Unit

Value (mean ± SD)

Reference range

Demographic characteristics

 Age

years

29.50 ± 6.49

 Height

cm

167.67 ± 5.61

 Body weight

kg

62.13 ± 5.35

 Body mass index (BMI)

kg/m²

22.08 ± 1.35

Liver function parameters

 Alanine aminotransferase (ALT)

U/L

15.72 ± 9.38

7–40

 Aspartate aminotransferase (AST)

U/L

21.23 ± 6.04

13–35

 AST/ALT ratio

1.518 ± 0.408

 Alkaline phosphatase (ALP)

U/L

65.00 ± 15.03

50–135

 Gamma-glutamyl transferase (GGT)

U/L

20.17 ± 9.41

11–50

 Total bilirubin (TBIL)

µmol/L

10.23 ± 3.21

0.0–17.1

 Direct bilirubin (DBIL)

µmol/L

2.675 ± 1.311

0.0–5.0

 Indirect bilirubin (IDIL)

µmol/L

7.550 ± 3.192

0.0–18.0

Protein and renal function parameters

 Total protein (TP)

g/L

74.30 ± 3.77

65.0–85.0

 Albumin (ALB)

g/L

43.25 ± 1.62

40.0–55.0

 Globulin (GLB)

g/L

31.05 ± 2.83

20.0–40.0

 Albumin/globulin ratio (A/G)

1.403 ± 0.127

1.20–2.40

 Uric acid (UA)

µmol/L

309.9 ± 52.60

137–393

 Serum creatinine (SCR)

µmol/L

67.17 ± 14.13

45–84

 Urea (UR)

mmol/L

5.780 ± 1.412

2.90–8.20

 Glucose (GLU)

mmol/L

4.743 ± 0.309

3.90–6.10

 Triglycerides (TG)

mmol/L

0.933 ± 0.250

0.0–1.70

 Total cholesterol (TC)

mmol/L

4.148 ± 0.804

0.00–5.20